Moley JF - Search Results

1

Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence.

Markovina S, Grigsby PW, Schwarz JK, DeWees T, Moley JF, Siegel BA, Perkins SM. Markovina S, et al. Among authors: moley jf. Thyroid. 2014 Jul;24(7):1121-6. doi: 10.1089/thy.2013.0297. Epub 2014 May 28. Thyroid. 2014. PMID: 24731094

2

Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.

Grigsby PW, Reddy RM, Moley JF, Hall BL. Grigsby PW, et al. Among authors: moley jf. Surgery. 2006 Dec;140(6):1043-7; discussion 1047-9. doi: 10.1016/j.surg.2006.08.007. Epub 2006 Nov 1. Surgery. 2006. PMID: 17188155

3

Lymph node metastases in differentiated thyroid cancer under 2 cm.

Reddy RM, Grigsby PW, Moley JF, Hall BL. Reddy RM, et al. Among authors: moley jf. Surgery. 2006 Dec;140(6):1050-4; discussion 1054-5. doi: 10.1016/j.surg.2006.08.010. Epub 2006 Nov 1. Surgery. 2006. PMID: 17188156

4

Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL. Finkelstein SE, et al. Among authors: moley jf. Ann Surg Oncol. 2008 Jan;15(1):286-92. doi: 10.1245/s10434-007-9611-5. Epub 2007 Sep 20. Ann Surg Oncol. 2008. PMID: 17882493

5

Prognostic factors in patients with well-differentiated thyroid cancer presenting with pulmonary metastasis.

Showalter TN, Siegel BA, Moley JF, Baranski TJ, Grigsby PW. Showalter TN, et al. Among authors: moley jf. Cancer Biother Radiopharm. 2008 Oct;23(5):655-9. doi: 10.1089/cbr.2008.0501. Cancer Biother Radiopharm. 2008. PMID: 18976119

6

Management of cervical nodal metastasis detected on I-131 scintigraphy after initial surgery of well-differentiated thyroid carcinoma.

Creach KM, Gillanders WE, Siegel BA, Haughey BH, Moley JF, Grigsby PW. Creach KM, et al. Among authors: moley jf. Surgery. 2010 Dec;148(6):1198-204; discussion 1204-6. doi: 10.1016/j.surg.2010.09.006. Surgery. 2010. PMID: 21134552

7

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma.

Henke LE, Pfeifer JD, Ma C, Perkins SM, DeWees T, El-Mofty S, Moley JF, Nussenbaum B, Haughey BH, Baranski TJ, Schwarz JK, Grigsby PW. Henke LE, et al. Among authors: moley jf. Cancer Med. 2015 Jun;4(6):791-9. doi: 10.1002/cam4.417. Epub 2015 Feb 25. Cancer Med. 2015. PMID: 25712893 Free PMC article.

8

Preparation of patients with thyroid cancer for 131I scintigraphy or therapy by 1-3 weeks of thyroxine discontinuation.

Grigsby PW, Siegel BA, Bekker S, Clutter WE, Moley JF. Grigsby PW, et al. Among authors: moley jf. J Nucl Med. 2004 Apr;45(4):567-70. J Nucl Med. 2004. PMID: 15073251 Free article.

9

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma. Wells SA Jr, et al. Among authors: moley jf. Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335. Thyroid. 2015. PMID: 25810047 Free PMC article. Review.

10

Medullary thyroid cancer: medical management and follow-up.

Traugott A, Moley JF. Traugott A, et al. Among authors: moley jf. Curr Treat Options Oncol. 2005 Jul;6(4):339-46. doi: 10.1007/s11864-005-0037-7. Curr Treat Options Oncol. 2005. PMID: 15967086 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters